Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients.
Ezzedine K, Diallo A, Léauté-Labrèze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cario-André M, Seneschal J, Boralevi F, Jouary T, Taieb A. Ezzedine K, et al. Among authors: seneschal j. Br J Dermatol. 2011 Jul;165(1):44-9. doi: 10.1111/j.1365-2133.2011.10311.x. Epub 2011 Jun 2. Br J Dermatol. 2011. PMID: 21410675
Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study.
Viguier M, Pagès C, Aubin F, Delaporte E, Descamps V, Lok C, Beylot-Barry M, Séneschal J, Dubertret L, Morand JJ, Dréno B, Bachelez H; Groupe Français de Recherche sur le Psoriasis. Viguier M, et al. Among authors: seneschal j. Br J Dermatol. 2012 Aug;167(2):417-23. doi: 10.1111/j.1365-2133.2012.10940.x. Epub 2012 Jun 11. Br J Dermatol. 2012. PMID: 22413927
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.
Prey S, Ezzedine K, Doussau A, Grandoulier AS, Barcat D, Chatelus E, Diot E, Durant C, Hachulla E, de Korwin-Krokowski JD, Kostrzewa E, Quemeneur T, Paul C, Schaeverbeke T, Seneschal J, Solanilla A, Sparsa A, Bouchet S, Lepreux S, Mahon FX, Chene G, Taïeb A. Prey S, et al. Among authors: seneschal j. Br J Dermatol. 2012 Nov;167(5):1138-44. doi: 10.1111/j.1365-2133.2012.11186.x. Epub 2012 Oct 5. Br J Dermatol. 2012. PMID: 23039171 Clinical Trial.
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, Maurouard T, Dougall D, Davizon ES, Dumortier H, Douchet I, Raffray L, Richez C, Lazaro E, Duffau P, Truchetet ME, Khoryati L, Mercié P, Couzi L, Merville P, Schaeverbeke T, Viallard JF, Pellegrin JL, Moreau JF, Muller S, Zurawski S, Coffman RL, Pascual V, Ueno H, Blanco P. Jacquemin C, et al. Among authors: seneschal j. Immunity. 2015 Jun 16;42(6):1159-70. doi: 10.1016/j.immuni.2015.05.012. Epub 2015 Jun 9. Immunity. 2015. PMID: 26070486 Free PMC article.
Clinical repigmentation patterns in paediatric vitiligo.
Gan EY, Gahat T, Cario-André M, Seneschal J, Ezzedine K, Taïeb A. Gan EY, et al. Among authors: seneschal j. Br J Dermatol. 2016 Sep;175(3):555-60. doi: 10.1111/bjd.14635. Epub 2016 Aug 6. Br J Dermatol. 2016. PMID: 27037527
219 results